Stock SEER SEER, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Seer, Inc.

Equities

SEER

US81578P1066

Real-time Estimate Cboe BZX
Other stock markets
 10:39:54 01/05/2024 pm IST 		5-day change 1st Jan Change
2.125 USD +2.16% Intraday chart for Seer, Inc. +19.55% +9.07%
29/02 Transcript : Seer, Inc., Q4 2023 Earnings Call, Feb 29, 2024
29/02 Seer, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Seer to Report First Quarter 2024 Financial Results on May 8, 2024
GL
Transcript : Seer, Inc., Q4 2023 Earnings Call, Feb 29, 2024
Seer, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Seer, Inc. Provides Revenue Guidance for the Full Year 2024
CI
Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook
GL
Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook
AQ
Earnings Flash (SEER) SEER Reports Q4 Revenue $4.4M, vs. Street Est of $4.05M
MT
Seer to Participate in the TD Cowen 44th Annual Health Care Conference
GL
Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery
GL
Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery
AQ
Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
GL
Transcript : Seer, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 03:00 PM
Seer, Inc. Announces Board and Committee Changes
CI
Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference
GL
Seer, Inc. Announces Management Changes
CI
Seer : Investor Presentation
PU
Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum
GL
Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500
GL
Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500
AQ
Transcript : Seer, Inc., Q3 2023 Earnings Call, Nov 07, 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SEER Stock
  4. News Seer, Inc.